Skip to main content
. 2018 Jan 10;2018(1):CD001905. doi: 10.1002/14651858.CD001905.pub3

Comparison 2. Intranasal lorazepam versus intramuscular paraldehyde.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Seizure cessation 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.1 Within 10 minutes 1 160 Risk Ratio (M‐H, Fixed, 95% CI) 1.22 [0.99, 1.52]
2 Additional drugs required to stop seizures 1 160 Risk Ratio (M‐H, Fixed, 95% CI) 0.38 [0.18, 0.81]
3 Seizure recurrence within 24 hours 1 160 Risk Ratio (M‐H, Fixed, 95% CI) 0.73 [0.31, 1.71]